This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences.  In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space. We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various ...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving.  In this report, we focus upon technical and business trends in these spaces as they are fast evolving.   CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis.  Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes. Select Biosciences has performed worldwide market tracking where...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine. Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives: All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described—a few have already been devel...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving.  In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces.  The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease.  In this manner, microRNA signatures may be validated as biomarkers in many disease areas—cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.  Select Biosciences has performed worldwide market tracking wherein we’ve analyzed end-user researc...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields.  In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events.  Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanismsThis report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs.This report also de...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of vendor...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof.

The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost factors. Mainly due to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach US$ 1,020 Billion by the end of 2012. This research study provides extensive and coherent information about pharmaceutical markets in emerging countries. It also gives a detailed statistical and analytical review on the demographics, macroeconomic indicators, disease profile, key drivers and restraints of the...

This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different countries of the world. This report analyzes the umbilical cord blood marketplace from a technical as well a...

The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is critical for cells to respond to and interact with their environments. But even without the complete revoluti...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics. This report details the current status of the cellular therapeutics marketplace, products that are commercialized, market potential, clinical trials pipeline and characterization of this pipeline by therapeutic class. The report also provides an analysis of the cellular therapeutics that are currently performed and categorizes them according to type/class of adult stem cell utilized as well as disease(s) treated. Thi...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers.

This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the cancer/oncology space. Cancer vaccines can be generated using a number of different approaches and this report describes these approaches vis-à-vis their advantages and disadvantages and associated technical characteristics. Indeed, the FDA-approval of a cancer vaccine for prostate cancer in 2010 was a key milestone in this space and a driver for R&D efforts forward. This report presents the pre-clinical pipeline, early-stage clinical tri...

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. 

This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. 

This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with parti...

Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. Omics technologies are beginning to be used to analyze genes, proteins, and metabolites in single cells, and beginning to meet the significant demand in applications such as cancer biology, stem cell biology, neurobiology, synthetic biology and biofuel and drug development, where understanding and manipulating the full complexity of intracellular pathways is the Holy Grail.  Omics...

This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stem cells space is broad and comprehensive-each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on presenting the market characteristics of stem cells as they are currently impacting research in the cellular therapy space. Furthermore, this report also addresses an important market, namely that of Umbilical Cord Blood Banking. Qualitative and Quantitative Trends in the Stem Cells Space: Quantitative Market Forecast (Market Size) by Product Class in the Stem Cells Space and Correspo...

This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends—both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of different research product vendors into the end-user community, products for microRNA research in the various...